https://gizmodo.com/these-melanoma-patients-got-a-vaccine-made-for-their-own-tumors-2-years-later-82-are-still-cancer-free-2000829831
Merck and Moderna released melanoma trial results early. The vaccine targets personal tumors. Eighty-two percent of patients remain cancer-free after two years.
Image:
#melanoma #vaccine #cancer #tumor
Merck and Moderna released melanoma trial results early. The vaccine targets personal tumors. Eighty-two percent of patients remain cancer-free after two years.
Image:
#melanoma #vaccine #cancer #tumor
Views: 1
Categories: News & Updates [c3], Projects & Resources [c5]